Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DONANEMAB-AZBT Cause Cognitive disorder? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Cognitive disorder have been filed in association with DONANEMAB-AZBT. This represents 1.1% of all adverse event reports for DONANEMAB-AZBT.

11
Reports of Cognitive disorder with DONANEMAB-AZBT
1.1%
of all DONANEMAB-AZBT reports
0
Deaths
0
Hospitalizations

How Dangerous Is Cognitive disorder From DONANEMAB-AZBT?

Of the 11 reports, and 1 (9.1%) were considered life-threatening.

Is Cognitive disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DONANEMAB-AZBT. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does DONANEMAB-AZBT Cause?

Amyloid related imaging abnormality-oedema/effusion (185) Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits (139) Headache (111) Infusion related reaction (97) Amyloid related imaging abnormalities (80) Flushing (68) Cerebral haemorrhage (54) Dizziness (48) Nausea (44) Cerebral microhaemorrhage (41)

What Other Drugs Cause Cognitive disorder?

CARBIDOPA\LEVODOPA (1,449) DIMETHYL (1,405) NATALIZUMAB (1,309) LEVOTHYROXINE (1,189) FINASTERIDE (1,074) INTERFERON BETA-1A (1,014) MORPHINE (929) FINGOLIMOD (919) CARBAMAZEPINE (849) AMITRIPTYLINE (834)

Which DONANEMAB-AZBT Alternatives Have Lower Cognitive disorder Risk?

DONANEMAB-AZBT vs DONEPEZIL DONANEMAB-AZBT vs DONEPEZIL\DONEPEZIL DONANEMAB-AZBT vs DONEPEZIL\MEMANTINE DONANEMAB-AZBT vs DONEPEZIL\OMEPRAZOLE\OMEPRAZOLE DONANEMAB-AZBT vs DONOR HUMAN STOOL

Related Pages

DONANEMAB-AZBT Full Profile All Cognitive disorder Reports All Drugs Causing Cognitive disorder DONANEMAB-AZBT Demographics